Table 3.
DNA methylation and Parkinson’s disease (PD).
| Gene/ protein |
Function | Mechanism | Reference |
|---|---|---|---|
| SNCA | Contributing to PD pathology | Increasing accumulation of α-synuclein and ROS production, affecting dopaminergic neuron function | (193) |
| TMCC2 | Contributing to PD pathology | Forming complexes with APOE and APP, regulating to Braak Lewy body staging | (189) |
| SLC7A11 | A biological target in PD | Transporting cystine and glutamate, disrupting glutathione levels and increasing oxidative stress | (190) |
| HOTAIR | Promoting neurodegeneration in PD | Influencing ERK1/2 signaling | (191) |
| PARK7 | Protecting cells from oxidative stress in PD | Impairing antioxidant function and resulting in dopaminergic neuron loss | (192) |
| SLC17A6 | Transporting glutamate in PD | Altering neurotransmitter release and vesicular transport | (192) |
| PTPRN2 | Protecting from PD | Impacting the function of insulin signaling-related proteins | (192) |
| NR4A2 | Protecting from PD | Affecting the development and function of dopaminergic neurons | (192) |